Pulmonary Delivery Of Mrna To Non-Lung Target Cells - EP2858679

The patent EP2858679 was granted to Ethris on Jun 5, 2024. The application was originally filed on Jun 7, 2013 under application number EP13800103A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2858679

ETHRIS
Application Number
EP13800103A
Filing Date
Jun 7, 2013
Status
Patent Maintained As Amended
May 3, 2024
Publication Date
Jun 5, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

FRKELLYNov 22, 2021FRKELLYWITHDRAWN

Patent Citations (43) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP20100742089
DESCRIPTIONEP2459231
DESCRIPTIONUS2008286834
DESCRIPTIONUS2009286852
DESCRIPTIONUS2012027803
DESCRIPTIONUS4373071
DESCRIPTIONUS4401796
DESCRIPTIONUS4415732
DESCRIPTIONUS4458066
DESCRIPTIONUS4500707
DESCRIPTIONUS4668777
DESCRIPTIONUS4897355
DESCRIPTIONUS4973679
DESCRIPTIONUS5047524
DESCRIPTIONUS5132418
DESCRIPTIONUS5153319
DESCRIPTIONUS5171678
DESCRIPTIONUS5262530
DESCRIPTIONUS5334761
DESCRIPTIONUS5700642
DESCRIPTIONUS5744335
DESCRIPTIONUS5780014
DESCRIPTIONUS5885613
DESCRIPTIONWO2005121348
DESCRIPTIONWO2008052770
DESCRIPTIONWO2010042877
DESCRIPTIONWO2010053572
DESCRIPTIONWO2011068810
DESCRIPTIONWO2012170889
DESCRIPTIONWO2012170930
INTERNATIONAL-SEARCH-REPORTUS2002192651
INTERNATIONAL-SEARCH-REPORTUS2004224912
INTERNATIONAL-SEARCH-REPORTUS2005158302
INTERNATIONAL-SEARCH-REPORTUS2009286852
INTERNATIONAL-SEARCH-REPORTUS2011244026
INTERNATIONAL-SEARCH-REPORTWO2006016097
INTERNATIONAL-SEARCH-REPORTWO2010056403
INTERNATIONAL-SEARCH-REPORTWO9810748
OPPOSITIONWO2012006376
OPPOSITIONWO2012006377
OPPOSITIONWO2012006378
OPPOSITIONWO2012170930
SEARCHWO9312756

Non-Patent Literature (NPL) Citations (12) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
OPPOSITION- Andries Oliwia, Marina De Filette, Joanna Reiman, Stefaan C. De Smedt, Jo Demeester, Mario Van Poucke, Luc Peelman, Cindy Peleman, Tony Lahoutte, Niek N. Sanders, "Comparison of the Gene Transfer Efficiency of mRNA/GL67 and pDNA/GL67 Complexes in Respiratory Cells", Molecular Pharmaceutics, (20120607), pages 2136 - 2145, XP055883653
OPPOSITION- Anonymous, "Cystic Fibrosis", National Institute of Health, (19951101), pages 1 - 6, XP055883645
OPPOSITION- Anonymous, "UniProtKB - P07988 (PSPB_HUMAN)", Database Uniprot KB, (20210929), pages 1 - 1, Database Uniprot KB, URL: https://www.uniprot.org/uniprot/P07988, (20220125), XP055883553
OPPOSITION- Anonymous, "Uniprot KB Q16637", Database Uniprot KB, (20210929), pages 1 - 1, Database Uniprot KB, URL: https:/ /www.uniprot.org/uniprot/Q16637, (20220125), XP055883662
OPPOSITION- Ma Feihe, Liu Yang, Zhuorui Sun, Jinjin Chen, Xuehui Rui, Zachary Glass, Qiaobing Xu, "Neurotransmitter-derived lipidoids (NT-iipidoids)for enhanced brain delivery through intravenous injection", Science Advances, (20200701), vol. 6, no. 30, page eabb4429, XP055883656
OPPOSITION- Mays L. E., Leon Gustafsson, Renate Koch, Eva Muellerhermelink, Markus Mezger, Rupert Handgretinger, Dominik Hartl, Michael S. D. Kormann., "Chemically Modified mRNA Encoding mFoxp3 Protects Against Airway Inflammation in a Murine Model of Allergic Asthma", Molecular Therapy, (20120501), vol. 20, no. 102, pages S42 - S43, XP055883620
OPPOSITION- Rubin, Staddon, "THE CELL BIOLOGY OF THE BLOOD-BRAIN BARRIER", Annu Rev Neurosci, (19990101), vol. 22, pages 11 - 28, XP055883658
OPPOSITION- Vieira W. A., Pretorius E., "The impact of asthma on the gastrointestinal tract (GIT)", Journal of Astham and Allergy, (20100101), vol. 3, pages 123 - 130, XP055883556
OPPOSITION- Wilder M. A., Msn, Rng, C-Nnp, "Surfactant Protein B Deficiency in Infants With Respiratory Failure", J Permat Neonat Nurs, (20040101), vol. 18, no. 1, pages 61 - 67, XP055883639
OPPOSITION- Amir K. Varkouhi; Marije Scholte; Gert Storm; Hidde J. Haisma;, "Endosomal escape pathways for delivery of biologicals", Journal of Controlled Release, Elsevier, AMSTERDAM, NL, AMSTERDAM, NL , (20101019), vol. 151, no. 3, doi:10.1016/j.jconrel.2010.11.004, ISSN 0168-3659, pages 220 - 228, XP028215423
OPPOSITION- Michael S D Kormann, Günther Hasenpusch, Manish K Aneja, Gabriela Nica, Andreas W Flemmer, Susanne Herber-Jonat, Marceline Huppmann, Lauren E Mays, Marta Illenyi, Andrea Schams, Matthias Griese, Iris Bittmann, Rupert Handgretinger, Dominik Hartl, Joseph Rosenecker, Carsten Rudolph, "Expression of therapeutic proteins after delivery of chemically modified mRNA in mice", Nature Biotechnology, Gale Group Inc., (20110201), vol. 29, no. 2, doi:10.1038/nbt.1733, ISSN 10870156, pages 154 - 157, XP055040839
OPPOSITION- Lorenzi Julio CC; Trombone Ana PF; Rocha Carolina D; Almeida Luciana P; Lousada Ricardo L; Malardo Thiago; Fontoura Isabela C; Rossetti Renata AM; Gembre Ana F; Silva Aristóbolo M; Silva Celio L; Coelho-Castelo Arlete AM, "Intranasal vaccination with messenger RNA as a new approach in gene therapy: Use against tuberculosis", BMC Biotechnology, BioMed Central Ltd, (20101020), vol. 10, no. 1, doi:10.1186/1472-6750-10-77, ISSN 1472-6750, page 77, XP021076472

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents